ATLANTA and SYDNEY – 21 September 2007. Life Therapeutics (ASX: LFE)
today announced that the Board of Directors has received an unsolicited offer of US$50 million cash from Octapharma AG for LFE's 14
operating plasma collection centres and the central testing laboratory.
- Forums
- ASX - By Stock
- life therapeutics announces unsolicited cash o
LFE
life therapeutics limited
ATLANTA and SYDNEY – 21 September 2007. Life Therapeutics (ASX:...
Featured News
Add LFE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online